Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Weiler

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Quality Assurance (San Diego, Calif.)|December 1, 1993
Personnel training: a key aspect of a quality program in the chemical process industryJ M Kauffman, E D Weiler
Quality Assurance (San Diego, Calif.)|October 1, 1991
Management of process change in a chemical companyJ W Parrott, E D Weiler
British Medical Journal|July 21, 1979
Long-acting nitrates in the prophylaxis of angina pectorisD Weiler-Ravell, M M Bassan
Quality Assurance (San Diego, Calif.)|June 1, 1992
Application of ISO 9002 and FDA's good manufacturing practices to general chemical manufacturingJ M Kauffman, E D Weiler
Health Facilities Management|June 7, 1992
Health care construction. What about cost control/budgets?J D Weiler, A L Johnson
Chest|February 1, 1983
The additive antianginal action of oral isosorbide dinitrate in patients receiving propranolol. Magnitude and duration of effectM M Bassan, D Weiler-Ravell
American Heart Journal|February 1, 1983
Effect of a twelve-hour hiatus in propranolol therapy on exercise tolerance in patients with angina pectorisM M Bassan, D Weiler-Ravell
The Alabama Journal of Medical Sciences|April 1, 1980
Sleep and its disorders: an overviewG V Pegram, P Hyde, D Weiler
Circulation|October 1, 1982
The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effectM Bassan, D Weiler-Ravell, O Shalev
British Medical Journal (Clinical Research Ed.)|April 10, 1982
Additive antianginal effect of verapamil in patients receiving propranololM Bassan, D Weiler-Ravell, O Shalev
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Quality Assurance (San Diego, Calif.)|December 1, 1993
Personnel training: a key aspect of a quality program in the chemical process industryJ M Kauffman, E D Weiler
Quality Assurance (San Diego, Calif.)|October 1, 1991
Management of process change in a chemical companyJ W Parrott, E D Weiler
British Medical Journal|July 21, 1979
Long-acting nitrates in the prophylaxis of angina pectorisD Weiler-Ravell, M M Bassan
Quality Assurance (San Diego, Calif.)|June 1, 1992
Application of ISO 9002 and FDA's good manufacturing practices to general chemical manufacturingJ M Kauffman, E D Weiler
Health Facilities Management|June 7, 1992
Health care construction. What about cost control/budgets?J D Weiler, A L Johnson
Chest|February 1, 1983
The additive antianginal action of oral isosorbide dinitrate in patients receiving propranolol. Magnitude and duration of effectM M Bassan, D Weiler-Ravell
American Heart Journal|February 1, 1983
Effect of a twelve-hour hiatus in propranolol therapy on exercise tolerance in patients with angina pectorisM M Bassan, D Weiler-Ravell
The Alabama Journal of Medical Sciences|April 1, 1980
Sleep and its disorders: an overviewG V Pegram, P Hyde, D Weiler
Circulation|October 1, 1982
The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effectM Bassan, D Weiler-Ravell, O Shalev
British Medical Journal (Clinical Research Ed.)|April 10, 1982
Additive antianginal effect of verapamil in patients receiving propranololM Bassan, D Weiler-Ravell, O Shalev
Pageof 10